Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

AMBRISENTAN for Systemic sclerosis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 172 adverse event reports in the FDA FAERS database where AMBRISENTAN was used for Systemic sclerosis.

Most Reported Side Effects for AMBRISENTAN

Side Effect Reports % Deaths Hosp.
Dyspnoea 13,367 15.5% 652 6,217
Death 7,497 8.7% 7,442 1,241
Headache 7,325 8.5% 203 1,884
Pneumonia 4,693 5.4% 368 3,802
Dizziness 4,561 5.3% 93 1,261
Fatigue 4,436 5.2% 145 1,312
Diarrhoea 4,312 5.0% 168 1,512
Nausea 3,986 4.6% 153 1,297
Fluid retention 3,927 4.6% 212 2,212
Malaise 3,839 4.5% 214 1,491
Peripheral swelling 3,461 4.0% 128 1,107
Cough 3,067 3.6% 85 899
Nasal congestion 3,019 3.5% 36 423
Oedema peripheral 2,959 3.4% 114 882
Oedema 2,651 3.1% 109 923

Other Indications for AMBRISENTAN

Product used for unknown indication (35,884) Pulmonary arterial hypertension (27,852) Pulmonary hypertension (18,885) Scleroderma (1,547) Cor pulmonale chronic (879) Connective tissue disorder (857) Heart disease congenital (772) Chronic obstructive pulmonary disease (460) Portopulmonary hypertension (428) Sleep apnoea syndrome (352)

Other Drugs Used for Systemic sclerosis

CYCLOPHOSPHAMIDE (68) FILGRASTIM (53) LETAIRIS (25) BOSENTAN\BOSENTAN (16) RITUXIMAB (12) TREPROSTINIL (10) MYCOPHENOLATE MOFETIL (8) IMATINIB (7) PREDNISOLONE (6) TOCILIZUMAB (5)

Related Pages

AMBRISENTAN Full Profile All Systemic sclerosis Drugs AMBRISENTAN Demographics AMBRISENTAN Timeline